Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04660812
Title An Open Label Study Evaluating the Efficacy and Safety of AB928 Based Treatment Combinations in Patients With Metastatic Colorectal Cancer.
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Arcus Biosciences, Inc.
Indications

colorectal adenocarcinoma

Therapies

AB680 + AB928 + Zimberelimab

Regorafenib

AB928 + Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + Zimberelimab

AB928 + Fluorouracil + Leucovorin + Oxaliplatin + Zimberelimab

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU


No variant requirements are available.